![](/img/cover-not-exists.png)
842TiPPROSABI: Prospective multi-centre study of prognostic factors in castration resistant prostate cancer (CRPC) patients treated with abiraterone acetate (AA)
Lorente Estelles, D., Puente, J., Medina, A., Lozano Mejorada, R., Rivera, L., Pacheco, M.I., Sáez, M.I., Piulats Rodriguez, J.M., Fernandez Parra, E.M., Borrega García, P., Pérez Valderrama, B., GallVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx370.059
Date:
September, 2017
File:
PDF, 75 KB
english, 2017